QuantBreadth | Market Internals retweeted
Stocks that hit 52-week highs on Friday
Well-known names in the list:
• WELSPUNLIV
• MAHABANK
• INDHOTEL
• COFORGE
• UNIONBANK
• KOTAKBANK
• FEDERALBNK
• ICICIBANK
• DLF
• APOLLOHOSP
• AXISBANK
Full list with 1 Day, 1 Week, 1 Month, YTD and RS Rating 👇
QuantBreadth | Market Internals retweeted
Years of backtesting and blown accounts, only to find out the holy grail of the stock market was GTA all along.
#GrandTheftAutoVI
QuantBreadth | Market Internals retweeted
Nifty PSU Bank Index is up ~18% in a straight line this month and just hit major resistance right at 9,909.
Vertical breakouts straight into previous highs fail way more often than people think.
Without a pullback or a few weeks of consolidation here, a breakout is usually just a trap for late buyers.
If you are holding PSU banks right now, stay alert and protect your gains.
QuantBreadth | Market Internals retweeted
Look at this $NVDA monthly chart.
Down ~45% from the highs and heading straight into the 50 month EMA around $131. It respected this exact level in 2019 and 2022 before going on massive runs.
Odds favor a reversal soon.
If $131 breaks on a monthly close though, there is vacum all the way down to $100.
Are you buying this test or waiting for $100?
QuantBreadth | Market Internals retweeted
Public Sector Bank and IT are leading today.
PSU Banks will have a correction/profit booking after such rally.
QuantBreadth | Market Internals retweeted
Anthropic employees will be sitting on $100 million after today's listing.
If you were to be one of those, will you be pocketing the $100M immediately and disappearing, or letting it ride for a shot at 10x and becoming a billionaire?
$ANT
QuantBreadth | Market Internals retweeted
$ANT listed at $111 with at 34% listing premium. A Stellar debut.
In the poll below, most have guessed that it will close the day below $100. Only person has guessed it to be above $100.
Poll is still open 👇
$ANT starts trading on Nasdaq in 2 hours.
Marketed IPO band was $70 to $78 (~$1.4T valuation). IPO priced above the $70–$78 range at $83 per share at ~$1.5T valuation after massive institutional demand.
Where does $ANT close at the end of Day 1?
33%Below $80 Post-open fade
33%$80 to $90
17%$90-$100
17%Above $100 Full euphoria
12 votes • Final results QuantBreadth | Market Internals retweeted
$ANT starts trading on Nasdaq in 2 hours.
Marketed IPO band was $70 to $78 (~$1.4T valuation). IPO priced above the $70–$78 range at $83 per share at ~$1.5T valuation after massive institutional demand.
Where does $ANT close at the end of Day 1?
33%Below $80 Post-open fade
33%$80 to $90
17%$90-$100
17%Above $100 Full euphoria
12 votes • Final results QuantBreadth | Market Internals retweeted
DCI gave a breakout today after moving sideways for 50 days.
It was in the confluence zone of EMIs, CPR and had double inside camarilla.
Sitting at 2R risk free trade now. Perks of being a microcap stock is it can move fast.
Not a recommendation.
QuantBreadth | Market Internals retweeted
IT is the laggard sector as of now, INFY being at the bottom of today's performance.
Coforge is looking good among all IT stocks
QuantBreadth | Market Internals retweeted
Anthropic lists tomorrow on Nasdaq as $ANT in one of the biggest IPOs in market history.
The numbers behind the debut:
• IPO Price Band: $70 to $78 per share
• Valuation: Up to $1.4 trillion
• Issue Size: $64.35 billion (825M shares)
• Revenue Run Rate: ~$81 billion annualized (up $10B in a single month)
• Compute Commitments: ~$901 billion locked in
Hyper-scale revenue growth colliding with massive infrastructure spend.
Are you buying $ANT on listing day, waiting for the post-IPO pullback, or staying away completely?
QuantBreadth | Market Internals retweeted
$AVGO is looking good in the monthly chart.
Taking support and forming a hammer at the 20EMA.
Last time it formed similar pattern in April 2025 and then rallied 👇
QuantBreadth | Market Internals retweeted
$NVDA has broken its monthly 20 EMA and is down ~15% from the EMA.
In the last 4 years, it dipped below the monthly 20 EMA only once (by ~10%) and still managed to close back above it by month-end.
Will it reclaim the 20 EMA by the end of November this time or close below it?
QuantBreadth | Market Internals retweeted
What did TradingView do this time?
Can't add drawings. Seeing this pop up for the first time.
Anyone else is experiencing this?
QuantBreadth | Market Internals retweeted
Only 15 stocks in Nifty50 closed in green today 👇
#NSEIndia
QuantBreadth | Market Internals retweeted
Intraday market breadth is weak across the board today.
Nifty 50, Next 50, Midcaps and Smallcaps - all showing poor participation.
#NSE
QuantBreadth | Market Internals retweeted
NVIDIA ( $NVDA ) Q3 FY27 Results: Revenue doubles YoY to $115.8B & Net Income hits $65.3B as Vera Rubin NVL72 shipping ramp accelerates
Global AI compute & accelerated infrastructure leader powering hyperscale data centers, sovereign AI factories, and edge computing platforms.
📅 Earnings: November 17, 2026
• Total Revenue: $115.8B (YoY: +103% | QoQ: +20%) - beats ~$109.2B consensus
• Operating Income (GAAP): $77.5B (YoY: +115% | QoQ: +22%)
• Gross Margin: 74.8% GAAP (+140 bps YoY | -20 bps QoQ) | 74.9% Non-GAAP
• Net Income (GAAP): $65.3B (YoY: +105% | QoQ: +9%)
└ Diluted EPS: $2.70 GAAP (+108% YoY) | $2.68 Non-GAAP (+111% YoY vs ~$2.47 est.)
📌 Segment Revenue & Vera Rubin Ramp Drivers:
• Data Center ($107.6B | 92.9% of Revenue): Surged +110% YoY and +21% QoQ
• Vera Rubin NVL72 Launch: Initial rack shipments commenced in Q3, adding nearly $20B in sequential revenue expansion with compute capacity fully utilized
• Edge Computing ($8.2B): Up +42% YoY and +14% QoQ, supported by RTX Spark AI laptops shipping across major OEMs
• Strategic Expansion: Announced an agreement to acquire Hugging Face alongside CUDA-Q Logical quantum and commercial AI-RAN telecom deployments
🎯 Q4 FY27 Outlook & Capital Allocation Catalysts:
• Q4 Revenue Guidance ($130.0B ± 3%): Implies ~12% sequential growth (includes an additional calendar week) and comfortably tops ~$125.2B Street expectations while assuming zero China Data Center compute revenue.
• Q4 Gross Margin Trajectory (71.0%-72.0%): GAAP and Non-GAAP gross margins guided to moderate ~300 bps sequentially as early Vera Rubin NVL72 rack manufacturing scales into volume.
• Balance Sheet & Shareholder Returns: Ended Q3 with ~$227.3B remaining under share repurchase authorization (bolstered by a $150B board increase) alongside a $0.25/share quarterly cash dividend.
💡 Key Insight:
1. Demand Unfazed by Executive Transition: In its first quarterly print following Jensen Huang's resignation and under interim CEO & CFO Colette Kress, NVIDIA doubled top-line revenue YoY to $115.8B and guided Q4 to $130.0B, confirming unbroken hyperscaler capex momentum.
2. Vera Rubin Takes the Baton: Vera Rubin NVL72 added nearly $20B in sequential revenue right out of the gate, though investors must digest a near-term gross margin dip to 71%-72% during early rack ramp-up.
3. Off-Balance-Sheet Commitments Surge: Supply commitments climbed to $390B (up from $279B QoQ), cloud/data center lease commitments hit $102B (up from $74B), and gross data center guarantee exposure stood at $118B, underscoring both multi-year visibility and rising ecosystem risk-sharing.
QuantBreadth | Market Internals retweeted
INDO-MIM Limited ( #INDOMIM ) Q2 FY27 Results: Consolidated PAT doubles YoY to ₹215.19 Cr as high-margin Defence, Aerospace & Medical segments scale
Global precision engineering leader in Metal Injection Molding (MIM), Investment Casting, and high-complexity precision components across Aerospace, Defence, Medical, and Automotive.
📅 Earnings: November 13, 2026
• Revenue from Operations: ₹1,271.84 Cr (YoY: +14.3% | QoQ: +4.4%)
└ Total Income (incl. ₹13.84 Cr Other Income): ₹1,285.68 Cr (YoY: +12.9% | QoQ: +4.1%)
• Operating Profit (EBITDA): ₹393.69 Cr (YoY: +23.4% | QoQ: -3.9%)
└ EBITDA Margin (on Op. Rev): 30.95% (+227 bps YoY | -266 bps QoQ)
• Profit Before Tax (PBT): ₹309.49 Cr (YoY: +107.3% | QoQ: -4.9%)
• Net Profit (PAT): ₹215.19 Cr (YoY: +99.95% | QoQ: -10.4%)
└ PAT Margin (on Op. Rev): 16.92% (+725 bps YoY | -278 bps QoQ) | Basic EPS: ₹4.38
📌 H1 FY27 Performance & Segment Mix Drivers:
• First-Half (H1 FY27) Scale: Consolidated operational revenue rose 11.8% YoY to ₹2,490.58 Cr | H1 EBITDA surged 37.9% YoY to ₹803.41 Cr (32.0% margin, +630 bps YoY) | H1 PAT jumped 57.0% YoY to ₹455.31 Cr (18.2% net margin)
• Technology Breakdown (H1): Core Metal Injection Molding (MIM) grew 19.8% YoY to ₹1,500.1 Cr (60% of revenue) | Investment Casting up 36.0% to ₹477.2 Cr | Precision Machining up 55.4% to ₹188.2 Cr | Electronics Components (ECM) down 40.5% to ₹268.1 Cr
• End-Market Surge (H1): Consumer (+46.2% YoY), Aerospace (+31.5% YoY), Medical (+22.7% YoY), Automotive (+19.4% YoY), and Defence (+19.3% YoY) drove structural mix upgrade
🎯 Full-Year Guidance, Return Ratios & Balance Sheet Monitorables:
• FY27 Guidance & Margin Normalization: Management set full-year FY27 targets of ₹5,000 Cr revenue and ₹850 Cr PAT (noting expectations to outperform), while flagging a normalized EBITDA margin corridor of 20–25% and PAT margin of 13–18% as Q1/Q2 benefited from lumpy tooling income and high defence/medical mix.
• Deleveraged Balance Sheet & Capital Efficiency: Post-IPO debt repayment (₹400 Cr from fresh issue proceeds) cut total borrowings from ₹1,255 Cr to ₹941 Cr, bringing Net Debt/EBITDA down to 0.19x (vs 0.75x YoY). H1 ROCE expanded 570 bps YoY to 36.5% and ROE reached 26.3%.
• Working Capital & Inventory Watch: Cash conversion cycle lengthened to 417 days in H1 FY27 (vs 324 days YoY) due to inventory days rising from 340 to 441 days, pulling H1 CFO/EBITDA conversion down to 55.3% (₹444.3 Cr operating cash flow).
💡 Key Insight:
1. Structural Margin & Profit Inflection: Consolidated Q2 PAT doubled YoY to ₹215.19 Cr (+100% YoY) as revenue mix shifted heavily toward high-margin Aerospace (+31.5%), Medical (+22.7%), and Defence (+19.3%) alongside lower post-IPO finance costs.
2. Sequential Normalization Is Built In: While Q2 EBITDA (₹393.69 Cr) and PAT (₹215.19 Cr) dipped sequentially against a Q1 peak boosted by one-off tooling revenues, H1 EBITDA margins at 32.0% remain well above management's steady-state 20–25% guidance band.
3. Inventory Build vs. H2 Cash Conversion: With H1 revenue at ₹2,490.6 Cr (~50% of the ₹5,000 Cr full-year target) and H1 PAT at ₹455.3 Cr (~54% of the ₹850 Cr target), executing against the 441-day inventory buildup in H2 will be critical to restoring 90%+ CFO/EBITDA conversion.














